Prevention and management of bleeding in thyroid surgery

Area of Science:

• Surgical Innovation
• Minimally Invasive Surgery
• Hemostasis Techniques

Background:

• Post-thyroidectomy neck hematoma is a significant surgical concern, potentially leading to life-threatening airway complications.
• Postoperative hemorrhage occurs in 0.1%–1.1% of thyroidectomies, primarily within 6 hours of surgery.
• Traditional clamp-and-tie methods are standard, with bipolar electrocautery limited to small vessels.

Purpose of the Study:

• To evaluate the efficacy of modern hemostatic systems in thyroid surgery.
• To compare energy devices and adjunctive hemostatic agents against traditional methods.
• To assess the impact of these innovations on operative time, costs, and complications.

Main Methods:

• Review of studies utilizing energy devices (advanced bipolar, ultrasound, hybrid) for thyroid pedicle division.
• Assessment of adjunctive hemostatic agents for managing small bleeds near critical structures.
• Comparison of outcomes including operative time, hemostasis effectiveness, and complication rates.

Main Results:

• Energy devices significantly decrease operative times in thyroid surgery.
• These devices do not increase costs or complication rates compared to traditional methods.
• Adjunctive hemostatic agents show comparable clinical significance when used with standard techniques.

Conclusions:

• Energy devices are effective and safe for thyroid surgery, improving efficiency.
• Adjunctive hemostatic agents provide valuable options for challenging bleeding scenarios.
• Modern hemostasis techniques enhance patient safety and surgical outcomes in thyroidectomies.